Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: Epidemiological survey

Epidemiology and Psychiatric Sciences

Volumn 22, Issue 4, 2013, Pages 355-361

  Barbui, C ^a   Conti, V ^b   Purgato, M ^a   Cipriani, A ^a   Fortino, I ^c   Rivolta, A L ^b   Lora, A ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b Regional Centre for Pharmacovigilance   (Italy)

^c Operative Unit of Territorial Health Services   (Italy)

^d Azienda Ospedaliera della Provincia di Lecco   (Italy)

Author keywords

childbearing age; Key words bipolar disorder; psychotropic drugs; schizophrenia

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; PSYCHOTROPIC AGENT;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; CHILDBEARING AGE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREGNANCY OUTCOME; PREVALENCE; SCHIZOPHRENIA; VAGINAL DELIVERY; YOUNG ADULT; ABORTION; COMORBIDITY; DATA BASE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG USE; EPIDEMIOLOGICAL DATA; FOLLOW UP; HOSPITALIZATION; INDUCED ABORTION; MENTAL HEALTH CARE; OUTPATIENT CARE; PREGNANCY; PRESCRIPTION; PSYCHIATRIST; PUBLIC HEALTH; REPRODUCTIVE HEALTH; PSYCHOLOGY; QUESTIONNAIRE;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; SURVEYS AND QUESTIONNAIRES;

EID: 84893203414     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796013000012     Document Type: Article

References (28)

1. Andrade SE, Kahler KH, Frech F, Chan KA (2006). Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety 15, 565-574. (Pubitemid 44336271)
2. Barbui C, Cipriani A (2011a). Cluster randomized trials. Epidemiology and Psychiatric Sciences 20, 307-309.
3. Barbui C, Cipriani A (2011b). What are evidence-based treatment recommendations? Epidemiology and Psychiatric Sciences 20, 29-31.
4. Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR (2009). Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials. Journal of Psychopharmacology 23, 574-591.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40, 373-383. (Pubitemid 17055592)
6. Conti V, Lora A, Cipriani A, Fortino I, Merlino L, Barbui C (2012). Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. European Journal of Clinical Pharmacology 68, 1647-1655.
7. Corrao G,Cesana G,MerlinoL(2008).Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy. Biomedical Statistics and Clinical Epidemiology 2, 117-125.
8. Einarson A, Boskovic R (2009). Use and safety of antipsychotic drugs during pregnancy. Journal of Psychiatric Practice 15, 183-192.
9. Eurostat (2007). European Regional and Urban Statistics Reference Guide. European Communities: Luxemburg.
10. Gentile S (2004). Clinical utilization of atypical antipsychotics in pregnancy and lactation. Annals of Pharmacotherapy 38, 1265-1271. (Pubitemid 38802173)
11. Gentile S (2010). Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophrenia Bulletin 36, 518-544.
12. Jentink J, Loane M, Dolk H, Barisic I, Garne E, Morris J, de Jong-van der Berg L (2010). Valproic acid monotherapy in pregnancy and major congenital malformations. New England Journal of Medicine 362, 2185-2193.
13. Jones G (2003). Prescribing and taking medicines. British Medical Journal 327, 819. (Pubitemid 37271687)
14. Leucht S,TardyM,KomossaK,HeresS,KisslingW,SalantiG, Davis JM(2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 379, 2063-2071.
15. Lora A (2009). An overview of the mental health system in Italy. Annali dell'Istituto Superiore di Sanita 45, 5-16.
16. Lora A, Barbato A, Cerati G, Erlicher A, Percudani M (2012). The mental health system in Lombardy, Italy: access to services and patterns of care. Social Psychiatry and Psychiatric Epidemiology 47, 447-454.
17. Lora A, Conti V, Leoni O, Rivolta AL (2011). Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy. Psychiatric Services 62, 1079-1084.
18. Meador K, Baker G, Finnell R (2006). In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67, 407-412. (Pubitemid 44214962)
19. Muller-Oerlinghausen B, Berghofer A, Bauer M (2002). Bipolar disorder. Lancet 359, 241-247. (Pubitemid 34113827)
20. National Institute for Health and Clinical Excellence (2007). Antenatal and Postnatal Mental Health. NICE: Great Britain.
21. Schwarz EB, Longo LS, Zhao X, Stone RA, Cunningham F, Good CB (2010). Provision of potentially teratogenic medications to female veterans of childbearing age. Medical Care 48, 834-842.
22. Soares-Weiser K, Bravo VY, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N (2007). A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technology Assessment 11, iii-206.
23. Sytema S, Micciolo R, Tansella M (1997). Continuity of care for patients with schizophrenia and related disorders: a comparative south-Verona and Groningen case-register study. Psychological Medicine 27, 1355-1362. (Pubitemid 27494101)
24. Tansella M, De Salvia D, Williams P (1987). The Italian psychiatric reform: some quantitative evidence. Social Psychiatry 22, 37-48.
25. Tansella M, Amaddeo F, Burti L, Lasalvia A, Ruggeri M (2006). Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatrica Scandinavica, Supplement 429, 90-94. (Pubitemid 43340895)
26. van Os J, Kapur S (2009). Schizophrenia. Lancet 374, 635-645.
27. WHO Collaborating Centre for Drug Statistic Methodology (2003). Guidelines for ATC Classification and DDD Assignment. WHO: Oslo.
28. World Health Organization (1992). Manual of the International Classification of Diseases, Injuries, and Causes of Death. World Health Organization: Geneva.